Filing Flows › Fresenius Medical Care AG (FMS) › Stock forecast & fair value
Fresenius Medical Care AG (FMS) stock forecast and price target
Fresenius Medical Care AG (FMS) trades at $23.40. 7 analysts' median price target is $22.62 (-3%), from $16.15 to $34.80.
Fresenius Medical Care AG's latest quarter
Fresenius Medical Care AG, Q3 2026: revenue $4.9B (+1% year over year), operating margin 7.8%, net earnings $160M, operating cash flow $798M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for FMS stock?
The median of 7 analysts' 12-month targets is $22.62, -3% from $23.40; the range is $16.15 to $34.80. The average rating is hold.
Does Fresenius Medical Care AG usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is FMS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.